Improving the Continuous Multiple Tube Reactor: an Innovative Bioreactor Configuration with Great Potential for Dark Fermentation Processes
Applied Biochemistry and Biotechnology · 2024
DOI: 10.1007/s12010-023-04553-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Biochemistry and Biotechnology, 2024. Verfasst von Ana Paula Trevisan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Post-Graduation in Agricultural Engineering, Western Parana State University, 2069, Universitária St., Jardim Universitário, Cascavel, PR, 5819-110, …. Hauptthemen laut MEDLINE: Sewage, Bioreactors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Fundação Araucária, Instituto Nacional de Ciência e Tecnologia da Criosfera.
Abstract (Originalsprache)
The continuous multiple tube reactor (CMTR) has been developed as a promising technology to maximize biohydrogen production (BHP) by dark fermentation (DF) by preventing excess biomass accumulation, leading to suboptimum values of specific organic loading rates (SOLR). However, previous experiences failed to achieve stable and continuous BHP in this reactor, as the low biomass retention capacity in the tube region limited controlling the SOLR. This study goes beyond the evaluation of the CMTR for DF by inserting grooves in the inner wall of the tubes to ensure better cell attachment. The CMTR was monitored in 4 assays at 25ºC using sucrose-based synthetic effluent. The hydraulic retention time (HRT) was fixed at 2 h, while the COD varied between 2-8 g L-1 to obtain organic loading rates in the 24 - 96 g COD L-1 d-1. Long-term (90 d) BHP was successfully attained in all conditions due to the improved biomass retention capacity. Optimal values for the SOLR (4.9 g COD g-1 VSS d-1) were observed when applying up to 48 g COD L-1 d-1, in which BHP was maximized. These patterns indicate a favorable balance between biomass retention and washout was naturally achieved. The CMTR looks promising for continuous BHP and is exempt from additional biomass discharge strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Post-Graduation in Agricultural Engineering, Western Parana State University, 2069, Universitária St., Jardim Universitário, Cascavel, PR, 5819-110, Brazil.
- Department of Biological and Environmental Sciences, Federal Technological University of Paraná, Av. Brasil, 4232, Parque Independência, Medianeira, PR, 85884-000, Brazil. lied.eduardo@gmail.com.
- Chemical Engineering Department, Polytechnic School, University of São Paulo (DEQ/EP/USP), Av. Prof. Lineu Prestes 580, Bloco 18 - Conjunto das Químicas, São Paulo, SP, 05508-000, Brazil.
- Biological Processes Laboratory (LPB), São Carlos School of Engineering (EESC), University of São Paulo (USP), Av. João Dagnone, 1100, Santa Angelina, São Carlos, SP, 13563-120, Brazil.
Förderung
- Fundação Araucária
- Instituto Nacional de Ciência e Tecnologia da Criosfera
Zitieren
APA
Trevisan, A. P., Lied, E. B., Fuess, L. T., Zaiat, M., de Souza, W. G., Gomes, S. D., & Gomes, B. M. (2024). Improving the Continuous Multiple Tube Reactor: an Innovative Bioreactor Configuration with Great Potential for Dark Fermentation Processes. Applied Biochemistry and Biotechnology. https://doi.org/10.1007/s12010-023-04553-3
Vancouver
Trevisan AP, Lied EB, Fuess LT, Zaiat M, de Souza WG, Gomes SD, et al. Improving the Continuous Multiple Tube Reactor: an Innovative Bioreactor Configuration with Great Potential for Dark Fermentation Processes. Applied Biochemistry and Biotechnology. 2024. doi:10.1007/s12010-023-04553-3
BibTeX
@article{Trevisan2024,
author = {Trevisan, Ana Paula and Lied, Eduardo Borges and Fuess, Lucas Tadeu and Zaiat, Marcelo and de Souza, Willyan Goergen and Gomes, Simone Damasceno and Gomes, Benedito Martins},
title = {Improving the Continuous Multiple Tube Reactor: an Innovative Bioreactor Configuration with Great Potential for Dark Fermentation Processes},
journal = {Applied Biochemistry and Biotechnology},
year = {2024},
doi = {10.1007/s12010-023-04553-3}
}
EUVIMED